Annual CFO
$25.38 M
+$20.10 M+380.57%
December 31, 2024
Summary
- As of March 6, 2025, CTKB annual cash flow from operations is $25.38 million, with the most recent change of +$20.10 million (+380.57%) on December 31, 2024.
- During the last 3 years, CTKB annual CFO has risen by +$20.75 million (+448.14%).
- CTKB annual CFO is now at all-time high.
Performance
CTKB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$2.00 M
-$11.22 M-84.90%
December 31, 2024
Summary
- As of March 6, 2025, CTKB quarterly cash flow from operations is $2.00 million, with the most recent change of -$11.22 million (-84.90%) on December 31, 2024.
- Over the past year, CTKB quarterly CFO has stayed the same.
- CTKB quarterly CFO is now -84.90% below its all-time high of $13.22 million, reached on September 30, 2024.
Performance
CTKB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$25.38 M
-$7.51 M-22.85%
December 31, 2024
Summary
- As of March 6, 2025, CTKB TTM cash flow from operations is $25.38 million, with the most recent change of -$7.51 million (-22.85%) on December 31, 2024.
- Over the past year, CTKB TTM CFO has stayed the same.
- CTKB TTM CFO is now -22.85% below its all-time high of $32.89 million, reached on September 30, 2024.
Performance
CTKB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CTKB Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +380.6% | 0.0% | 0.0% |
| 3 y3 years | +448.1% | +170.1% | +2047.7% |
| 5 y5 years | +284.6% | +170.1% | +2047.7% |
CTKB Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +307.5% | -84.9% | +121.2% | -22.9% | +295.6% |
| 5 y | 5-year | at high | +284.6% | -84.9% | +121.2% | -22.9% | +295.6% |
| alltime | all time | at high | +284.6% | -84.9% | +121.2% | -22.9% | +295.6% |
Cytek Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $25.38 M(+380.6%) | $2.00 M(-84.9%) | $25.38 M(-22.8%) |
| Sep 2024 | - | $13.22 M(+113.1%) | $32.89 M(+113.1%) |
| Jun 2024 | - | $6.20 M(+56.8%) | $15.43 M(+141.9%) |
| Mar 2024 | - | $3.96 M(-58.4%) | $6.38 M(+20.8%) |
| Dec 2023 | $5.28 M(-143.2%) | $9.51 M(-324.4%) | $5.28 M(+169.2%) |
| Sep 2023 | - | -$4.24 M(+48.7%) | $1.96 M(-250.6%) |
| Jun 2023 | - | -$2.85 M(-199.7%) | -$1.30 M(-83.5%) |
| Mar 2023 | - | $2.86 M(-53.9%) | -$7.89 M(-35.5%) |
| Dec 2022 | -$12.23 M | $6.19 M(-182.5%) | -$12.23 M(-5.7%) |
| Sep 2022 | - | -$7.50 M(-20.5%) | -$12.98 M(+201.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$9.44 M(+537.8%) | -$4.31 M(-454.8%) |
| Mar 2022 | - | -$1.48 M(-127.2%) | $1.22 M(-73.8%) |
| Dec 2021 | $4.63 M(-69.5%) | $5.45 M(+369.3%) | $4.63 M(-57.2%) |
| Sep 2021 | - | $1.16 M(-129.7%) | $10.82 M(-8.7%) |
| Jun 2021 | - | -$3.91 M(-302.3%) | $11.85 M(-24.2%) |
| Mar 2021 | - | $1.94 M(-83.4%) | $15.65 M(+3.2%) |
| Dec 2020 | $15.16 M(-210.2%) | $11.64 M(+431.3%) | $15.16 M(+331.2%) |
| Sep 2020 | - | $2.19 M(-1910.7%) | $3.52 M(+165.5%) |
| Jun 2020 | - | -$121.00 K(-108.4%) | $1.32 M(-8.4%) |
| Mar 2020 | - | $1.45 M | $1.45 M |
| Dec 2019 | -$13.75 M | - | - |
FAQ
- What is Cytek Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Cytek Biosciences?
- What is Cytek Biosciences annual CFO year-on-year change?
- What is Cytek Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cytek Biosciences?
- What is Cytek Biosciences quarterly CFO year-on-year change?
- What is Cytek Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Cytek Biosciences?
- What is Cytek Biosciences TTM CFO year-on-year change?
What is Cytek Biosciences annual cash flow from operations?
The current annual CFO of CTKB is $25.38 M
What is the all time high annual CFO for Cytek Biosciences?
Cytek Biosciences all-time high annual cash flow from operations is $25.38 M
What is Cytek Biosciences annual CFO year-on-year change?
Over the past year, CTKB annual cash flow from operations has changed by +$20.10 M (+380.57%)
What is Cytek Biosciences quarterly cash flow from operations?
The current quarterly CFO of CTKB is $2.00 M
What is the all time high quarterly CFO for Cytek Biosciences?
Cytek Biosciences all-time high quarterly cash flow from operations is $13.22 M
What is Cytek Biosciences quarterly CFO year-on-year change?
Over the past year, CTKB quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Cytek Biosciences TTM cash flow from operations?
The current TTM CFO of CTKB is $25.38 M
What is the all time high TTM CFO for Cytek Biosciences?
Cytek Biosciences all-time high TTM cash flow from operations is $32.89 M
What is Cytek Biosciences TTM CFO year-on-year change?
Over the past year, CTKB TTM cash flow from operations has changed by $0.00 (0.00%)